Combination of a proton pump inhibitor and a respiratory agent for the treatment of respiratory diseases

Details for Australian Patent Application No. 2003229771 (hide)

Owner ALTANA PHARMA AG

Inventors Hanauer, Guido; Simon, Wolfgang-Alexander; Kromer, Wolfgang; Postius, Stefan

Agent Griffith Hack

Pub. Number AU-A-2003229771

PCT Number PCT/EP03/04657

PCT Pub. Number WO2003/094968

Priority 02010306.5 07.05.02 EP

Filing date 3 May 2003

Wipo publication date 11 November 2003

International Classifications

A61K 045/06 Medicinal preparations containing active ingredients not provided for in groups

A61P 011/00 Drugs for disorders of the respiratory system

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 02010306.5 07.05.02 EP

15 January 2004 Application Open to Public Inspection

  Published as AU-A-2003229771

27 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

3 December 2009 Corrigenda

  Applications OPI - Name Index Under the name ALTANA Pharma AG, Application No. 2003229771, under INID (43) correct the publication date to read 24.11.2003 Corrigenda

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003229772-DERIVATIVES OF 2-(1-BENZYL-1H-PYRAZOLO (3, 4-B)PYRIDINE-3YL) - 5-(4-PYRIDINYL)-4-PYRIMIDINE AMINE AND THE USE THEREOF AS GUANYLATE CYCLASE STIMULATORS

2003229770-Bisphosphonic acid for the treatment and prevention of osteoporosis